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Abstract: Dermatofibroma is a common benign fibrohistiocytic tumor with many clinicopathological variants. 
Myxoid dermatofibroma is one of these variants, which is characterized by marked stromal mucin deposition. 
This report presents a case of myxoid dermatofibroma on a great toe that had been slowly growing for two years. 
Histopathologically, the relatively well-circumscribed dermal tumor was separated from the epidermis by a small 
grenz zone. The tumor tissue consisted of oval to spindle-shaped cells with well-defined cell borders and spindly 
condensed nuclei. No cytologic atypia or mitotic figures were found. Although most of the tumor cells were embed-
ded in a prominently myxoid stroma, typical features of classic dermatofibroma including a storiform growth pattern 
and more densely packed collagen were observed at the periphery. Immunohistochemically, the tumor cells showed 
positive staining for CD68 and CD99, and negative staining for CD34 and S-100. Histopathological differential 
diagnoses of myxoid dermatofibroma include soft tissue neoplasms with myxoid tumor stroma, such as superficial 
acral fibromyxoma, cellular digital fibroma, superficial angiomyxoma, myxoid dermatofibrosarcoma protuberans and 
low-grade fibromyxoid sarcoma. Immunohistochemical staining can be useful in the differential diagnosis of these 
tumors. This case highlights the challenges encountered in the histopathological interpretation of myxoid derma-
tofibroma. Pathologists should keep in mind the diagnosis of myxoid dermatofibroma when dealing with myxoid 
neoplastic lesions arising on acral sites.
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Introduction
Dermatofibroma is a common benign fibrohis-
tiocytic tumor of unknown etiology [1]. Due to 
varied histopathological aspects, synonymous 
designations include benign fibrous histiocyto-
ma, histiocytoma cutis, nodular subepidermal 
fibrosis and fibrous xanthoma [2]. Over the last 
three decades numerous distinctive clinico-
pathological variants have been described. 
Myxoid dermatofibroma is a very rare variant 
of dermatofibroma, which is characterized by 
marked stromal mucin deposition. Only 12 
cases of myxoid dermatofibroma have been 
reported in the literature [1-3]. We present a 
case of myxoid dermatofibroma arising on a 
great toe. This is an unusual site for such a rare 
lesion. Although any surface of the skin may be 
affected, dermatofibromas are most common 
on the lower extremities [4]. Presentation of 
dermatofibroma on the digits is not commonly 
reported in the literature [5, 6]. We describe the 
clinicopathological findings of digital myxoid 
dermatofibroma and also discuss the immuno-
histochemical staining results.
Case presentation
A 46-year-old Korean woman, with no relevant 
medical history, presented with a 2-year history 
of a slowly enlarging subungual mass on the 
right great toe. The lesion was asymptomatic, 
even though she professed tenderness when 
the mass was pressed and complained that it 
was impossible to wear shoes. She denied any 
history of antecedent trauma. Physical exami-
nation revealed a firm, round hyperkeratotic 
mass of 15 mm in diameter, which distorted the 
whole nail plate. Roentgenographic examina-
tion did not reveal any bony alteration. An initial 
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clinical diagnosis of digital wart was consid-
ered. Complete routine laboratory examina-
tions including hematological and biochemical 
tests revealed no abnormalities. A complete 
surgical excision of the distal phalanx was 
performed.
Pathologic findings
Histopathological examination of the excised 
specimen revealed a relatively well-circum-
scribed dermal lesion with a small grenz zone 
towards the epidermis (Figure 1A). The cutane-
ous tumor extended to the subcutaneous tis-
sue but did not invade the bony trabeculae. 
Higher magnifications showed a mildly to mod-
erately dense infiltrate of ovoid to spindle-
shaped cells similar in size to ordinary fibro-
cytes (Figure 1B). These cells had well-defined 
cell borders with spindly condensed nuclei. 
There was no cytologic atypia, and mitotic fig-
ures were not found. Most of the tumor cells 
were embedded in a prominently myxoid, well 
to moderately vascularized stroma (Figure 1C). 
A vascular network consisting of elongated cap-
illaries with narrow lumina was seen, but no 
erythrocyte extravasation was found. Occasi- 
onal lymphocytes and plasma cells were inter-
spersed within the stroma. At the periphery 
these changes gradually faded with typical fea-
tures of classic dermatofibroma, including a 
storiform growth pattern (Figure 1D) and more 
densely packed, focally sclerotic collagen. In 
some areas, there were alternating fibrotic 
areas with myxoid stroma (Figure 1E). 
Immunohistochemical staining revealed strong 
reactivity of tumor cells for CD68 (Figure 1F) 
and CD99 (Figure 1G), whereas they were neg-
Figure 1. Histopathological and immunohistochemical findings. A. A relatively well-circumscribed, unencapsulated 
cutaneous tumor was observed, with a small grenz zone towards the epidermis. B. Higher magnifications showed 
a moderately dense infiltrate of ovoid to spindle-shaped cells. C. The tumor cells were embedded in a prominently 
myxoid, well to moderately vascularized stroma. D. Some areas of the periphery exhibited typical features of classic 
dermatofibroma including a storiform growth pattern. E. Alternating areas of fibrotic and myxoid stroma were also 
observed. Immunohistochemically, the tumor cells expressed strong reactivity for F. CD68 and G. CD99, whereas 
they were negative for H. CD34 and I. S-100. CD34, which highlights the vascular endothelial cells, serves as inter-
nal positive control.
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ative for CD34 (Figure 1H) and S-100 (Figure 
1I). A 9-month follow-up examination showed 
no evidence of tumor recurrence or metastatic 
disease.
Discussion
Dermatofibroma is a reactive hyperplastic 
response of the skin of unknown etiology, which 
is mostly seen on the extremities of young or 
middle-aged women [2, 3]. A wide variety of 
clinicopathological variants of dermatofibro-
mas has been described over the last decade, 
including fibrocollagenous, vascular, angioma-
toid, sclerosing, palisading, epithelioid, atypi-
cal, clear cell, myofibroblastic and cellular 
types. Myxoid dermatofibroma is very rare, 
accounting for only 0.4% of all dermatofibro-
mas [2]. This frequency is similar to other rare 
variants, such as palisading, clear cell or myofi-
broblastic types. Mucinous material is a unspe-
cific finding [7], which can be found in a variety 
of benign and malignant lesions [2]. It is uncom-
mon for dermatofibroma to contain abundant 
myxoid matrix, but one should consider its myx-
oid variant if myxoid areas interface with bet-
ter-developed storiform architecture. 
Unawareness of this feature may cause misin-
terpretations, most likely as other cutaneous 
myxoid tumors. This happens in particular 
when attention is not paid to peripheral por-
tions. It can be difficult to consider the possibil-
ity of dermatofibroma if one merely examines 
the central portions showing myxoid stroma. 
Histopathological differential diagnoses inclu- 
de several soft tissue neoplasms showing myx-
oid matrix, such as superficial acral fibromyxo-
ma, cellular digital fibroma, superficial angio-
myxoma, cellular myxoma of soft tissue, myxoid 
neurofibroma, myxoid dermatofibrosarcoma 
protuberans and low-grade fibromyxoid sarco-
ma. The most important entity in the histopath-
ological differential diagnosis of the present 
case was superficial acral fibromyxoma. The 
tumor location preferred superficial acral fibro-
myxoma to myxoid dermatofibroma. Further- 
more, from a histologic standpoint, the tumor 
contained fibroblast-like cells embedded in a 
myxoid or myxocollagenous matrix with moder-
ately accentuated vasculature, suggesting the 
diagnosis of superficial acral fibromyxoma. 
However, superficial acral fibromyxoma is more 
myxoid compared with myxoid dermatofibroma, 
and does not have alternating zones of fibrotic 
and myxoid stroma. Most importantly, whereas 
superficial acral fibromyxoma commonly ex- 
press CD34, this antigen is rarely found in der-
matofibroma [2, 8]. Even though there may 
occasionally be an increase of CD34 expres-
sion at the periphery of the lesion, which 
derives from the intrinsic reactivity of the sur-
rounding stromal tissue response, this finding 
is in sharp contrast to superficial acral fibro-
myxoma and dermatofibrosarcoma protuber-
ans, which are usually diffusely and strongly 
positive for CD34. The fibrohistiocytic origin of 
myxoid dermatofibroma is indicated by several 
characteristics shared with classic dermatofi-
bromas: predilection for the lower legs of young 
to adult women, preservation of storiform pat-
tern in the periphery, immunoreactivity for his-
tiocytic marker CD68 and a benign clinical 
course with no recurrence. CD68-positive/
CD34-negative immunophenotype, together 
with the presence of histopathologic features 
of classic dermatofibroma, is useful in the dif-
ferential diagnosis.
Cellular digital fibroma is a benign tumor that 
usually develops in the fingers and toes. This 
tumor is superficially located and consists of 
monomorphic spindle cells arranged in a stori-
form pattern and immersed in a stroma with 
abundant collagen. Unlike myxoid dermatofi-
broma, cellular digital fibromas display a lower 
degree of vascularization in comparison with 
myxoid dermatofibroma, and the stroma is 
more fibrotic than myxoid [9, 10]. Immuno- 
histochemically, the spindle cells of cellular 
digital fibroma strongly express CD34, but are 
usually negative for CD99. Superficial angio-
myxoma is most common in the head, neck and 
trunk, and is exceedingly rare in acral sites. 
They display multilobulated appearance and a 
prominent vascular component with a neutro-
philic infiltrate scattered within the lesion. The 
tumor cells of superficial angiomyxoma also 
express CD34, and immunostaining for CD99 is 
characteristically negative. Cellular myxoma of 
soft tissue is a CD34-positive subcutaneous 
soft tissue tumor, developing most times within 
a muscle, rarely occurring on hands or feet [11]. 
Myxoid neurofibroma should be also consid-
ered in the histopathological differential diag-
nosis. This variant of neurofibroma reveals con-
sistent immunoreactivity for S-100 and does 
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not show the increased vasculature of myxoid 
dermatofibroma. Myxoid dermatofibrosarcoma 
protuberans is exceedingly uncommon, and as 
other variants of dermatofibrosarcoma protu-
berans, almost never occurs on the fingers and 
toes. It shows areas of classic dermatofibrosar-
coma protuberans when the neoplasm is ade-
quately excised; the spindle cells are arranged 
in a storiform pattern and extends into the sub-
cutaneous with a typical honeycomb pattern, 
and paucicellular myxoid areas are surrounded 
by more typical areas. Furthermore, myxoid 
dermatofibrosarcoma protuberans is immuno-
reactive for CD34. Low-grade fibromyxoid sar-
coma is a deep soft tissue tumor that only 
exceptionally arises on the fingers or toes. 
Although it can display alternating fibrous and 
myxoid areas, it is characterized by homoge-
neous whirling growth of spindle cells in heavily 
collagenized stroma and abrupt transition from 
fibrous to myxoid areas.
We observed CD99 immunoreactivity in the 
tumor cells of myxoid dermatofibroma. Data on 
CD99 staining in dermatofibromas are limited, 
with only a few random reports available in 
the literature that show mixed results. Der- 
matofibroma reportedly does not does not 
express CD99 [12, 13], although in a recent 
study, diffuse and strong CD99 immunoreactiv-
ity CD99 was detected in all dermatofibromas 
examined [14]. Tumors of fibrohistiocytic origin 
have been reported to show CD99 positivity 
[14]. Role of CD99 immunostaining in the dif-
ferential diagnosis of dermatofibroma remains 
controversial.
In summary, we describe a case of myxoid vari-
ant of dermatofibroma on a great toe, a loca-
tion not hitherto described in the literature. 
Because of its rarity, myxoid dermatofibroma 
may be confused with other myxoid lesions. A 
thorough examination for the presence of typi-
cal features of classic dermatofibroma and 
immunohistochemical staining are helpful in 
the differential diagnosis.
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